Therapeutic perspective of thiosemicarbazones derivatives in inflammatory pathologies: A summary of in vitro/in vivo studies
- 1 July 2021
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 96, 107778
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinaseNature Communications, 2013
- Induction and molecular signature of pathogenic TH17 cellsNature Immunology, 2012
- PGE2‐EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κBBritish Journal of Pharmacology, 2011
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Macrophages, Inflammation, and Insulin ResistanceAnnual Review of Physiology, 2010
- Degradation of Activated Protein Kinases by UbiquitinationAnnual Review of Biochemistry, 2009
- Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase HomodimersJournal of Biological Chemistry, 2009
- Acetaminophen: Antipyretic or hypothermic in mice? In either case, PGHS-1b (COX-3) is irrelevantProstaglandins & Other Lipid Mediators, 2008
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006